← Back
Data updated: Jul 17, 2026
TARO PHARMS NORTH
Pharma Pharmaceuticals
TARO PHARMS NORTH is a pharmaceutical company with 1 FDA-approved products.
1992
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
TARO PHARMS NORTH's Key Drugs
TARO PHARMS NORTH's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
TARO PHARMS NORTH's Recent FDA Approvals
New NDA/BLA approvals for TARO PHARMS NORTH over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
TARO PHARMS NORTH's Therapeutic Areas
Disease areas where TARO PHARMS NORTH has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
TARO PHARMS NORTH Pipeline Snapshot
Active clinical trials for TARO PHARMS NORTH across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1992-11-20
- Latest
- 1999-12-30
- Applications
- 1